Sale!

Oncopro NCCN Lung Cancer Panel with PD-L1 Test

28,080 د.إ

-10%

The “Oncopro NCCN Lung Cancer Panel with PD-L1 Test” is a comprehensive diagnostic tool utilized in the assessment and management of lung cancer, adhering to the guidelines set by the National Comprehensive Cancer Network (NCCN). This advanced panel is designed to analyze a wide array of genetic markers associated with lung cancer, offering insights into the molecular profile of the tumor. This information is crucial for determining the most effective treatment strategies, including targeted therapies and immunotherapies.

A significant component of this panel is the PD-L1 test, which measures the expression of the PD-L1 protein on the surface of tumor cells. PD-L1 plays a key role in suppressing the immune system and allowing cancer cells to evade detection and destruction by immune cells. Understanding the PD-L1 status of a tumor can guide oncologists in selecting immunotherapy treatments, which can be more effective for patients with high PD-L1 expression.

The test is available at DNA Labs UAE, a leading diagnostic facility known for its state-of-the-art technology and expertise in genetic and molecular testing. The cost of the “Oncopro NCCN Lung Cancer Panel with PD-L1 Test” at DNA Labs UAE is 28,080 AED. Given the complexity and the detailed insights it provides into the genetic makeup of lung cancer, this test represents a valuable investment in personalized cancer care, enabling tailored treatment plans that can significantly improve patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOPRO NCCN LUNG CANCER PANEL WITH PD-L1 Test

Test Name: ONCOPRO NCCN LUNG CANCER PANEL WITH PD-L1 Test

Components: *EGFR *ALK *ERBB2 *BRAF *MET *RET *ROS1 *NTRK1 *KRAS*MSI *PD-L1

Price: 28080.0 AED

Sample Condition: 20 mL whole blood in 2 Streck tubes available from LPL AND 8 mL whole blood in 1 Lavender Top (EDTA) tube. Add the preservative supplied in the collection kit to the EDTA tube using a syringe & needle. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32) is mandatory.

Report Delivery: 35 Working days

Method: Next Generation Sequencing, Extraction, Staining

Test type: Cancer

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32) is mandatory.

Test Details

The Oncopro NCCN Lung Cancer Panel with PD-L1 Test is a diagnostic test used to detect lung cancer and assess the expression of PD-L1, a protein that can help predict the response to certain immunotherapy treatments. The test analyzes genetic mutations and other biomarkers in the tumor tissue to determine the best treatment options for the patient.

It is based on the National Comprehensive Cancer Network (NCCN) guidelines, which are widely accepted as the standard of care for cancer treatment. The PD-L1 test measures the amount of PD-L1 protein present on the surface of tumor cells. This information can help determine if the patient is a candidate for certain immunotherapy drugs that target the PD-L1 pathway.

Overall, the Oncopro NCCN Lung Cancer Panel with PD-L1 Test is a valuable tool for physicians in making treatment decisions for patients with lung cancer.

Test Name ONCOPRO NCCN LUNG CANCER PANEL WITH PD-L1 Test
Components *EGFR *ALK *ERBB2 *BRAF *MET *RET *ROS1 *NTRK1 *KRAS*MSI *PD-L1
Price 28080.0 AED
Sample Condition 20 mLwhole bloodin 2 Streck tubes available from LPL AND8 mL whole bloodin 1 Lavender Top (EDTA) tube. Add the preservative supplied in the collection kit to the EDTA tube using a syringe & needle. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32)is mandatory.
Report Delivery 35 Working days
Method Next Generation Sequencing, Extraction, Staining
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled OncoPro Liquid Biopsy Clinical Information Form (Form 32)is mandatory.
Test Details

The Oncopro NCCN Lung Cancer Panel with PD-L1 Test is a diagnostic test used to detect lung cancer and assess the expression of PD-L1, a protein that can help predict the response to certain immunotherapy treatments.

The test analyzes genetic mutations and other biomarkers in the tumor tissue to determine the best treatment options for the patient. It is based on the National Comprehensive Cancer Network (NCCN) guidelines, which are widely accepted as the standard of care for cancer treatment.

The PD-L1 test measures the amount of PD-L1 protein present on the surface of tumor cells. This information can help determine if the patient is a candidate for certain immunotherapy drugs that target the PD-L1 pathway.

Overall, the Oncopro NCCN Lung Cancer Panel with PD-L1 Test is a valuable tool for physicians in making treatment decisions for patients with lung cancer.